Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Cefadroxil Capsules USP, 500 mg (base) Barr ANDA 65-015 6/22/99 6/22/99 Cefadroxil for Suspension USP Powder, 125 mg/5 mL, 250 mg/5 mL, and 500 mg/5 mL, Ranbaxy ANDA 65-115 3/26/03 Cefadroxil Tablets USP, 1 g base Ranbaxy ANDA 65-018 Duricef® (cefadroxil monohydrate, USP) Capsules, Suspension & Tablets, Bristol-Myers Squibb Company NDA 50-512/S-044, 50-527/S-020 & 50-528/S-018 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL APOTHECON 065015 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL Barr 062766 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL Ivax 050512 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE DURICEF WARNER CHILCOTT 065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 125MG BASE/5ML CEFADROXIL Ranbaxy 065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 250MG BASE/5ML CEFADROXIL Ranbaxy 065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 500MG BASE/5ML CEFADROXIL Ranbaxy 050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 125MG BASE/5ML DURICEF WARNER CHILCOTT 050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 250MG BASE/5ML DURICEF WARNER CHILCOTT 050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 500MG BASE/5ML DURICEF WARNER CHILCOTT 065018 CEFADROXIL/CEFADROXIL HEMIHYDRATE Tablet; 1GM BASE CEFADROXIL Ranbaxy 050528 CEFADROXIL/CEFADROXIL HEMIHYDRATE Tablet; 1GM BASE DURICEF WARNER CHILCOTT Duricef (cefadroxil monohydrate, USP) Capsules, Oral Suspension & Tablets, Bristol-Myers Squibb Company | Cefadroxil Oral Suspension, Teva Pharma, Approval | Cefadroxil Capsule, Teva Pharma, Approval | Cefadroxil Capsules, Hikma Pharma, Approval | Cefadroxil Tablets, Hikma Pharma, Approval | Cefadroxil Tablets, Orchid healthcare, Approval | Cefadroxil Oral Suspension, Orchid Healthcare, Approval | Cefadroxil Capsules, Aurobindo Pharma, Approval | Cefadroxil Capsules, Lupin Ltd., Approval | Duricef (cefadroxil monohydrate) Capsules, Warner Chilcott, Labeling Revision | Duricef (cefadroxil monohydrate) Oral Suspension, Warner Chilcott, Labeling Revision | Duricef (cefadroxil monohydrate) Tablets, Warner Chilcott, Labeling Revision | Cefadroxil Oral Suspension, Lupin, Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2009 Betterchem.com